Columbia University.. Ziyad Al-Aly> "Long COVID-19: Do

New Post Public Reply Private Reply Replies (2) Message Board
FKAdamF.
608
Columbia University.. Ziyad Al-Aly] "Long COVID-19: Do Patients Who Have Recovered From Acute Respiratory Symptoms Still Have a Higher Risk of Death? How Can Health Systems Prepare for Post COVID-19 Care?"
Very interesting video on VuMedi which I cannot figure out how to share its content with you without a membership.
This is not over yet!! LL is gonna be around helping so many with so many health related issues.
These guys are going on and on about severity of symptoms by these patients and so many other potential problems with opioid addictions and organ failures and physiological problems lasting for several years.
Try to watch it if you can or sign up for membership, it’s free.
I contacted them about LL and also asked Nader to reach out to them since they are well respected and heavily connected group which will help us with positive PR and attention.
Our drug is needed and those aware of its potential are doing so much to drag us down and break down our morals and make us submit and “Tap”. I never “Tap” and will not give up my shares and won’t get scared out of my pants like so many despite being down almost 7 figures.
We have a CEO, who is not perfect but he is resilient and determined to make this work. He wants nothing more than to prove people wrong and that plays well into his personality.
What should we do ? Hang on man!!! Don’t open your brokers accounts and don’t see your portfolio balance!!!
Don’t let your friends and family members who bought a ton of shares (based on your recommendation and enthusiasm) disappointed looks and sarcastic remarks and texts affect you too much.
Keep reading the board and hope to finally open something of huge importance and value to help lessen the pain of all your losses of “paper money”.
I have no idea if these new guys are gonna suddenly make us a 10$ stock again by their presence but I do know if it’s gonna be 10$ again , it won’t be because of them. It will get there based on the success of something with our trials and nothing else.
No matter what positive PR we get , stock goes down !! Right ? We get a F..g patent issued, price goes down. We get another mile stone achieved with long haulers , price goes down. What we need is something major with our trials and maybe little help from media.
So for now , we continue to go to work and do what we do and keep our minds sharp and not let these bashers and scums scare you out of your shares.
1.50$ is cheap for what this drug can do.
Have a good one my friends and good luck to all except Dr Frank and eefffeww, his cousin.

https://www.vumedi.com/video/do-covid-19-pati...l_id=86187

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 3

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 5

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 4

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding KBR, Inc.'s Legal Concerns and Investor Rights

Updated Category News Views 148

Investor Rights in KBR, Inc. Legal Matters In the realm of securities, investor rights play a pivotal role, especially for shareholders like those of KBR, Inc. (NYSE: KBR). The renowned Rosen Law Firm is conducting an investigation into claims that KBR may have provided misleading business information, potentially impacting the confidence of its investors. Allegations and...

Continue Reading
Jones Day Elevates 37 Lawyers to Partnership in Major Move

Updated Category News Views 121

Jones Day Expands Partnership with New Entrants In a significant development for the global law firm, Jones Day has officially announced the elevation of 37 lawyers to its partnership. This decision marks a notable moment for the firm's future, reflecting its ongoing commitment to delivering exceptional legal guidance to clients worldwide. Strengthening Global Presence...

Continue Reading
Equasens Strengthens Market Position through Strategic Acquisition

Updated Category News Views 242

Equasens Expands Its Reach in Healthcare Software Solutions Equasens Group, a prominent player in the healthcare software industry, has made a significant move by acquiring the DIS and ResUrgences businesses. This strategic acquisition, completed by its AXIGATE LINK Division, firmly establishes the company as a leading provider of software solutions tailored for hospitals...

Continue Reading
Upcoming Leadership Changes at Paul Mueller Company Revealed

Updated Category News Views 245

Leadership Transition at Paul Mueller Company Paul Mueller Company (OTC: MUEL) has announced a significant change in its leadership, with the retirement of Chief Financial Officer Kenneth E. Jeffries paving the way for Daniel L. Winters to take on this vital role. This transition, reflecting the company’s focus on growth, will take place on December 5, 2025. Introducing...

Continue Reading
Opera's CFO Set to Share Insights at Major Investor Conferences

Updated Category News Views 103

Opera's Key Investor Conferences Participation Opera Limited (NASDAQ: OPRA), a prominent player in the global browser and AI technology landscape, has announced that Frode Jacobsen, the Chief Financial Officer, will present at several significant upcoming investor conferences. These events are critical for engaging with investors and providing valuable insights into the...

Continue Reading